- Home
- AGI vs MEDP Comparison
AGI vs MEDP Comparison
Compare AGI & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGI
- MEDP
- Stock Information
- Founded
- AGI 2003
- MEDP 1992
- Country
- AGI Canada
- MEDP United States
- Employees
- AGI N/A
- MEDP N/A
- Industry
- AGI Precious Metals
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- AGI Basic Materials
- MEDP Health Care
- Exchange
- AGI Nasdaq
- MEDP Nasdaq
- Market Cap
- AGI 14.8B
- MEDP 13.4B
- IPO Year
- AGI 1999
- MEDP 2016
- Fundamental
- Price
- AGI $33.95
- MEDP $591.27
- Analyst Decision
- AGI Strong Buy
- MEDP Hold
- Analyst Count
- AGI 3
- MEDP 12
- Target Price
- AGI $41.00
- MEDP $465.18
- AVG Volume (30 Days)
- AGI 3.8M
- MEDP 311.3K
- Earning Date
- AGI 10-29-2025
- MEDP 10-22-2025
- Dividend Yield
- AGI 0.30%
- MEDP N/A
- EPS Growth
- AGI 112.89
- MEDP 25.36
- EPS
- AGI 1.28
- MEDP 14.32
- Revenue
- AGI $1,609,300,000.00
- MEDP $2,358,373,000.00
- Revenue This Year
- AGI $39.28
- MEDP $21.48
- Revenue Next Year
- AGI $27.13
- MEDP $11.90
- P/E Ratio
- AGI $26.45
- MEDP $41.23
- Revenue Growth
- AGI 31.30
- MEDP 13.88
- 52 Week Low
- AGI $17.80
- MEDP $250.05
- 52 Week High
- AGI $37.54
- MEDP $625.00
- Technical
- Relative Strength Index (RSI)
- AGI 57.95
- MEDP 59.85
- Support Level
- AGI $31.72
- MEDP $573.07
- Resistance Level
- AGI $34.37
- MEDP $609.13
- Average True Range (ATR)
- AGI 1.19
- MEDP 16.87
- MACD
- AGI 0.30
- MEDP -3.75
- Stochastic Oscillator
- AGI 93.12
- MEDP 50.88
About AGI Alamos Gold Inc.
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has four operating segments being Young-Davidson, Island Gold and Magino mines operate in Canada, and the Mulatos mine operates in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.